相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Small Molecule Kinase Inhibitor Drugs (1995-2021): Medical Indication, Pharmacology, and Synthesis
Cecilia C. Ayala-Aguilera et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Pharmacokinetics and brain distribution studies of 6-hydroxykynurenic acid and its structural modified compounds
Zhuowei Shen et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2022)
Scalable and selective deuteration of (hetero) arenes
Wu Li et al.
NATURE CHEMISTRY (2022)
Deucravacitinib for the Treatment of Psoriatic Disease
Ana Maria Le et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2022)
Deuterated Drugs and Biomarkers in the COVID-19 Pandemic
Ross D. Jansen-van Vuuren et al.
ACS OMEGA (2022)
An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline
Silvio Aprile et al.
ACS MEDICINAL CHEMISTRY LETTERS (2022)
Deucravacitinib: First Approval
Sheridan M. Hoy
DRUGS (2022)
Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2
Yuanchao Xie et al.
CELL RESEARCH (2021)
Donafenib: First Approval
Susan J. Keam et al.
DRUGS (2021)
Discovery of Dosimertinib, a Highly Potent, Selective, and Orally Efficacious Deuterated EGFR Targeting Clinical Candidate for the Treatment of Non-Small-Cell Lung Cancer
Yonggang Meng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review
Priyanka Singh et al.
MEDICAL ONCOLOGY (2021)
Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2021)
FGFR-TKI resistance in cancer: current status and perspectives
Sitong Yue et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia-From Molecular Mechanisms to Clinical Relevance
Raquel Alves et al.
CANCERS (2021)
Phase I clinical trial of HC-1119: A deuterated form of enzalutamide
Xiaoyu Li et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
Shukui Qin et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now
Ilana Schlam et al.
NPJ BREAST CANCER (2021)
Deuteration enhances the anti-tumor effects and relative anti-inflammatory effects via affecting proliferation and apoptosis
Ao Li et al.
HELIYON (2021)
Thiazole-containing compounds as therapeutic targets for cancer therapy
Prabodh Chander Sharma et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Limitations in Clinical Trials Leading to Anticancer Drug Approvals by the US Food and Drug Administration
Talal Hilal et al.
JAMA INTERNAL MEDICINE (2020)
Electrolytic deuteration of unsaturated bonds without using D2
Aiko Kurimoto et al.
NATURE CATALYSIS (2020)
Direct reversible decarboxylation from stable organic acids in dimethylformamide solution
Duanyang Kong et al.
SCIENCE (2020)
Detailed molecular cytogenetic characterisation of the myeloid cell line U937 reveals the fate of homologous chromosomes and shows that centromere capture is a feature of genome instability
Ruth N. MacKinnon et al.
MOLECULAR CYTOGENETICS (2020)
H-D Exchange Deuteration of Arenes at Room Temperature
Yoshinari Sawama et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2019)
Deuterated Curcuminoids: Synthesis, Structures, Computational/Docking and Comparative Cell Viability Assays against Colorectal Cancer
Kenneth K. Laali et al.
CHEMMEDCHEM (2019)
Design, synthesis of orally bioavailable novel anaplastic lymphoma kinase (ALK) inhibitor diphenylaminopyrimidine analogs and efficacy study on NCI-H2228 xenografts mice model
Debasis Das et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors
Marjan Yaghmaie et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)
Deoxygenative Deuteration of Carboxylic Acids with D2O
Muliang Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Applications of Deuterium in Medicinal Chemistry
Tracey Pirali et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design, synthesis and biological evaluation of deuterated Vismodegib for improving pharmacokinetic properties
Fangying Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease
Marissa Dean et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Drug metabolism in drug discovery and development
Zhoupeng Zhang et al.
ACTA PHARMACEUTICA SINICA B (2018)
Role of Cytochrome P450 Enzymes in the Metabolic Activation of Tyrosine Kinase Inhibitors
Klarissa D. Jackson et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Evaluation of Deuterium-Labeled JNJ38877605: Pharmacokinetic, Metabolic, and in Vivo Antitumor Profiles
Zhengsheng Zhan et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2018)
Deuterated drugs; updates and obviousness analysis
Graham S. Timmins
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Biological and photochemical degradation of cytostatic drugs under laboratory conditions
Helena Franquet-Griell et al.
JOURNAL OF HAZARDOUS MATERIALS (2017)
Effect of N-methyl deuteration on pharmacokinetics and pharmacodynamics of enzalutamide
Xuchai Pang et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2017)
Design, synthesis, and biological evaluation of deuterated apalutamide with improved pharmacokinetic profiles
Xuehai Pang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Development of MBRI-001, a deuterium-substituted plinabulin derivative as a potent anti-cancer agent
Zhongpeng Ding et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Drug Metabolism in the Liver
Omar Abdulhameed Almazroo et al.
CLINICS IN LIVER DISEASE (2017)
Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development
Jay Tibbitts et al.
MABS (2016)
Current Challenges in Cancer Treatment
Jon Zugazagoitia et al.
CLINICAL THERAPEUTICS (2016)
Design, synthesis and biological evaluation of deuterated Tivozanib for improving pharmacokinetic properties
Shiwei Guo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
A Simple and Cost-Effective Method for the Regioselective Deuteration of Phenols
Miao Zhan et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2015)
Design, synthesis and biological evaluation of deuterated nintedanib for improving pharmacokinetic properties
Ruixue Xu et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2015)
Ruthenium Catalyzed Selective α- and α,β-Deuteration of Alcohols Using D2O
Basujit Chatterjee et al.
ORGANIC LETTERS (2015)
Hydroxylation and N-Dechloroethylation of Ifosfamide and Deuterated Ifosfamide by the Human Cytochrome P450s and Their Commonly Occurring Polymorphisms
Diane M. Calinski et al.
DRUG METABOLISM AND DISPOSITION (2015)
Using Deuterium in Drug Discovery: Leaving the Label in the Drug
Thomas G. Gant
JOURNAL OF MEDICINAL CHEMISTRY (2014)
PharmGKB summary: ifosfamide pathways, pharmacokinetics and pharmacodynamics
Daniella Lowenberg et al.
PHARMACOGENETICS AND GENOMICS (2014)
The kinetic deuterium isotope effect as applied to metabolic deactivation of imatinib to the des-methyl metabolite, CGP74588
Paul W. Manley et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Resistance to Tyrosine Kinase Inhibition Therapy for Chronic Myelogenous Leukemia: A Clinical Perspective and Emerging Treatment Options
Elias J. Jabbour et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
Understanding the mechanism of cytochrome P450 3A4: recent advances and remaining problems
Irina F. Sevrioukova et al.
DALTON TRANSACTIONS (2013)
The background, discovery and clinical development of BCR-ABL inhibitors
Gemma K. Lambert et al.
DRUG DISCOVERY TODAY (2013)
Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
Jolieke G. van Oosterwijk et al.
BMC CANCER (2012)
A deuterated analog of dasatinib disrupts cell cycle progression and displays anti-non-small cell lung cancer activity in vitro and in vivo
Chunhua Ling et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line
Ramez N. Eskander et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2012)
Ruthenium-Catalyzed Selective α,β-Deuteration of Bioactive Amines
Lorenz Neubert et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Mild Reaction Conditions for the Terminal Deuteration of Alkynes
Sean P. Bew et al.
ORGANIC LETTERS (2012)
Principles of early drug discovery
J. P. Hughes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Small-molecule protein kinase inhibitors and their effects on the immune system: implications for cancer treatment
Patrick A. Ott et al.
IMMUNOTHERAPY (2011)
Synthesis of deuterium-labelled drugs by hydrogen-deuterium (H-D) exchange using heterogeneous catalysis
Nkaelang Modutlwa et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2010)
Lung Cancer Cell Lines as Tools for Biomedical Discovery and Research
Adi F. Gazdar et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Cancer stem cells from colorectal cancer-derived cell lines
Trevor M. Yeung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Characterization of stem cell attributes in human osteosarcoma cell lines
Lin Wang et al.
CANCER BIOLOGY & THERAPY (2009)
Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
Emmanuelle Charafe-Jauffret et al.
CANCER RESEARCH (2009)
Tyrosine Kinase Inhibitors - A Review on Pharmacology, Metabolism and Side Effects
Joerg Thomas Hartmann et al.
CURRENT DRUG METABOLISM (2009)
Identification and Expansion of Human Osteosarcoma-Cancer-Stem Cells by Long-Term 3-Aminobenzamide Treatment
Riccardo Di Fiore et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
CAL 27 is an oral adenosquamous carcinoma cell line
Lu Jiang et al.
ORAL ONCOLOGY (2009)
Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery
Jessica Kao et al.
PLOS ONE (2009)
Hodgkin Lymphoma Cell Lines Are Characterized by a Specific miRNA Expression Profile
Johan H. Gibcus et al.
NEOPLASIA (2009)
A Convenient and Effective Method for the Regioselective Deuteration of Alcohols
Tomohiro Maegawa et al.
ADVANCED SYNTHESIS & CATALYSIS (2008)
Efficient and convenient heterogeneous palladium-catalyzed regioselective deuteration at the benzylic position
Thkanori Kurita et al.
CHEMISTRY-A EUROPEAN JOURNAL (2008)
A simple, cost-effective method for the regioselective deuteration of anilines
Andrew Martins et al.
ORGANIC LETTERS (2008)
Derivatives of tramadol for increased duration of effect
LM Shao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Targeted CML therapy: controlling drug resistance, seeking cure
T O'Hare et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2006)
Role of tyrosine kinase inhibitors in cancer therapy
A Arora et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Platelet-derived growth factor receptor (PDGFR): A target for anticancer therapeutics
R Board et al.
DRUG RESISTANCE UPDATES (2005)
Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549
XL Yin et al.
LIFE SCIENCES (2004)
Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms
M Ingelman-Sundberg
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines
S Mehra et al.
GENES CHROMOSOMES & CANCER (2002)
ADME/PK as part of a rational approach to drug discovery
PJ Eddershaw et al.
DRUG DISCOVERY TODAY (2000)
分享论文
